Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tactile Systems TechnologyFRA:3L3 -3.50%79 Net Margin % is 9.08% as of Jun. 2026, which is 82% above its 10-year median of 4.99. GuruFocus rates FRA:3L3 with a GF Score™ of 79/100 and a GF Value™ of €15.73 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Tactile Systems Technology ranks better than 64.38% on this metric.
The historical rank and industry rank for Tactile Systems Technology's Net Margin % or its related term are showing as below:
FRA:3L3'
s Net Margin % Range Over the Past 10 Years
Min: -7.24 Med: 4.99 Max: 10.39
Current: 7.1
FRA:3L3's Net Margin % is ranked better than 64.38% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.2
vs FRA:3L3: 7.10
Tactile Systems Technology (FRA:3L3) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Tactile Systems Technology Net Margin % Related Terms
Tactile Systems Technology Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3L3 vs CBLL, CERS, CTKB: Net Margin % Comparison
For the Medical Devices subindustry, Tactile Systems Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Net Margin % distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (FRA:3L3) has a Net Margin % of 9.08% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Tactile Systems Technology and its competitors. This is 82% above median its historical median of 4.99. According to the industry distribution chart, Tactile Systems Technology ranks #291 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 35.6%.
Is Tactile Systems Technology's Net Margin % too high?
Tactile Systems Technology's current Net Margin % of 9.08% is 82% above median its 10-year median of 4.99. The Medical Devices & Instruments industry median Net Margin % is 2.20. Tactile Systems Technology's value of 9.08% is 312.7% above this industry median. Based on the distribution chart, Tactile Systems Technology ranks #291 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tactile Systems Technology has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's Net Margin % compare to CBLL and CERS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #291 out of 817 companies for Net Margin %. This puts Tactile Systems Technology in the upper half of its industry. The industry median Net Margin % is 2.20. Tactile Systems Technology's value of 9.08% is 312.7% above this benchmark. While the company's 10-year median is 4.99 vs. the industry median of 2.20, Tactile Systems Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.20, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current Net Margin % of 9.08% is 312.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current Net Margin % is 9.08%, which is 82% above median its own 10-year median of 4.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (FRA:3L3) is currently considered Modestly Overvalued. The stock's GF Value™ is €15.73, compared to a current price of €20.38 — trading 29.6% above its estimated fair value. The current Net Margin % is 9.08%, which is 82% above median its 10-year median of 4.99 and 312.7% above the Medical Devices & Instruments industry median of 2.20. Tactile Systems Technology's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tactile Systems Technology (FRA:3L3), the current Net Margin % is 9.08% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (FRA:3L3) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of €20.38 is trading 29.6% above its estimated GF Value™ of €15.73.
GuruFocus considers Tactile Systems Technology to be Modestly Overvalued.
Key valuation signals for FRA:3L3:
Net Margin %: 9.08% (82% above median its 10-year median of 4.99)
GF Value™: €15.73 vs. price of €20.38 (29.6% above fair value)
Industry Position: 312.7% above the Medical Devices & Instruments median (#291 of 817)
No single metric tells the full story. See the FRA:3L3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
79GF Score
Get the complete analysis for FRA:3L3
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3L3 has been successfully added to your 
